e2f 1 (Cell Signaling Technology Inc)
Structured Review
E2f 1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 682 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e2f/E2F-1+Antibody/pmc12892985-6-0-4
Average 96 stars, based on 682 article reviews
Images
Related Articles
Western Blot:Article Title: Separate transcription and splicing gene networks are linked and coordinated by the pRb–E2F pathway Article Snippet: .. The following antibodies were used in immunoblots: β-actin (clone AC-74, Sigma–Aldrich, St. Louis, USA), Article Title: M1C Mediates LINE-1 Transcription in PARP Inhibitor-Treated Prostate Cancer Cells. Article Snippet: This is a PDF of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability.. This version will undergo additional copyediting, typesetting and review before it is published in its final form.. As such, this version is no longer the Accepted Manuscript, but it is not yet the definitive Version of Record; we are providing this early version to give early visibility of the article. Cell-Signaling:Article Title: Separate transcription and splicing gene networks are linked and coordinated by the pRb–E2F pathway Article Snippet: .. The following antibodies were used in immunoblots: β-actin (clone AC-74, Sigma–Aldrich, St. Louis, USA), Article Title: A CDK-4EBP1 signaling axis drives HSV-1 replication and underscores a druggable pathway for potent antiviral intervention Article Snippet: Phospho-Rb (Ser608) , #2181 , Cell Signaling Technologies, USA , 110. .. Blocking Assay:Article Title: Cuproptosis-associated PDHA1 promotes sarcoma progression and immunotherapy responsiveness via the E2F1-PD-L1 axis: a multi-omics and clinical validation study. Article Snippet: .. After blocking with 5% non-fat milk for 1 h at room temperature, membranes were incubated overnight at 4 °C with primary antibodies against PDHA1 (ab168379, Abcam), Incubation:Article Title: Cuproptosis-associated PDHA1 promotes sarcoma progression and immunotherapy responsiveness via the E2F1-PD-L1 axis: a multi-omics and clinical validation study. Article Snippet: .. After blocking with 5% non-fat milk for 1 h at room temperature, membranes were incubated overnight at 4 °C with primary antibodies against PDHA1 (ab168379, Abcam), Article Title: “Targeting LARP1 Enhances Carboplatin Sensitivity and Suppresses Tumor Growth in Endometrial Cancer” Article Snippet: .. Cells were then incubated overnight at 4 °C with the following primary antibodies: LARP1 (Cat. No. sc-515873; 1:200 dilution; Santa Cruz Biotechnology, Dallas, TX, USA) and Control:Article Title: Cuproptosis-associated PDHA1 promotes sarcoma progression and immunotherapy responsiveness via the E2F1-PD-L1 axis: a multi-omics and clinical validation study. Article Snippet: .. After blocking with 5% non-fat milk for 1 h at room temperature, membranes were incubated overnight at 4 °C with primary antibodies against PDHA1 (ab168379, Abcam), Article Title: Multi-omics profiling reveals homologous recombination repair hyperactivation as a therapeutic vulnerability in neuroendocrine cervical carcinoma. Article Snippet: Chromatin was sheared to 200–500 bp fragments using a Covaris ultrasonicator. .. After preclearing with Protein G magnetic beads, Magnetic Beads:Article Title: Multi-omics profiling reveals homologous recombination repair hyperactivation as a therapeutic vulnerability in neuroendocrine cervical carcinoma. Article Snippet: Chromatin was sheared to 200–500 bp fragments using a Covaris ultrasonicator. .. After preclearing with Protein G magnetic beads, Immunoprecipitation:Article Title: Multi-omics profiling reveals homologous recombination repair hyperactivation as a therapeutic vulnerability in neuroendocrine cervical carcinoma. Article Snippet: Chromatin was sheared to 200–500 bp fragments using a Covaris ultrasonicator. .. After preclearing with Protein G magnetic beads, |

